ストックスクリーナーアプリを入手
47.08
1.30%
-0.62
アフターアワーズ：
47.50
0.42
+0.89%
Praxis Precision Medicines Inc (PRAX) 最新ニュース
Protect Your Investment: Contact Levi & Korsinsky About the Praxis Precision Medicines, Inc. (PRAX) Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Praxis Precision Medicines, Inc. (PRAX) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc. - GlobeNewswire Inc.
Praxis Precision Medicines Inc. stock momentum explainedQuarterly Market Summary & Real-Time Volume Analysis Alerts - Newser
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Is Praxis Precision Medicines Inc. meeting your algorithmic filter criteriaPortfolio Growth Summary & Consistent Return Investment Signals - Newser
How to monitor Praxis Precision Medicines Inc. with trend dashboardsGlobal Markets & Weekly Return Optimization Alerts - Newser
Should you hold or exit Praxis Precision Medicines Inc. nowJuly 2025 Final Week & Safe Entry Trade Signal Reports - Newser
Lost Money on Praxis Precision Medicines, Inc. (PRAX)? Possible FraudContact Levi & Korsinsky Today - ACCESS Newswire
Applying sector rotation models to Praxis Precision Medicines Inc.Market Performance Report & Verified Momentum Watchlists - Newser
Praxis Precision Medicines: Navigating Clinical Setbacks and the Biotech Investment Tightrope - AInvest
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc.PRAX - PR Newswire
Advanced analytics toolkit walkthrough for Praxis Precision Medicines Inc.Portfolio Risk Summary & Safe Swing Trade Setup Alerts - Newser
Can Praxis Precision Medicines Inc. rally from current levelsMarket Risk Analysis & Consistent Return Strategy Ideas - Newser
How Praxis Precision Medicines Inc. stock performs during market volatility2025 Year in Review & Low Risk High Reward Trade Ideas - Newser
What indicators show strength in Praxis Precision Medicines Inc.2025 Volume Leaders & Weekly Return Optimization Alerts - Newser
Why Praxis Precision Medicines Inc. stock attracts strong analyst attentionWeekly Stock Report & Technical Confirmation Trade Alerts - Newser
Is Praxis Precision Medicines Inc. stock reversal real or fake2025 Bull vs Bear & High Return Trade Opportunity Guides - Newser
Did Praxis Precision Medicines, Inc. (PRAX) Mislead Investors? Levi & Korsinsky Investigates - ACCESS Newswire
Reversal indicators forming on Praxis Precision Medicines Inc. stockStop Loss & Accurate Entry/Exit Alerts - Newser
Bronstein, Gewirtz & Grossman, LLC Encourages Praxis Precision Medicines, Inc. (PRAX) Investors to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Praxis Precision Medicines, Inc. (PRAX) And Encourages Investors to Reach Out - ACCESS Newswire
Praxis Precision Medicines shares fall 1.89% intraday after Schall Law Firm investigates claims of false statements. - AInvest
Levi & Korsinsky Investigates Possible Securities Fraud by Praxis Precision Medicines, Inc. (PRAX) - ACCESS Newswire
PRAX Investors Have Opportunity to Join Praxis Precision Medicines, Inc. Fraud Investigation with the Schall Law Firm - Barchart.com
Will Praxis Precision Medicines Inc. bounce back from current supportGap Up & Safe Capital Allocation Plans - Newser
Does Praxis Precision Medicines Inc. stock pay reliable dividends2025 Buyback Activity & Precise Buy Zone Tips - Newser
Levi & Korsinsky Investigating Whether Praxis Precision Medicines, Inc. (PRAX) Misled InvestorsSecurities Law Violations Possible - ACCESS Newswire
What are the future prospects of Praxis Precision Medicines Inc.Volume Surge With Low Float - thegnnews.com
Will Praxis Precision Medicines Inc. see short term momentumRisk-Managed Trade Alerts for Consistency - Newser
Investigation Alert: Levi & Korsinsky Investigates Securities Fraud Claims Against Praxis Precision Medicines, Inc. (PRAX) - ACCESS Newswire
Piper Sandler reiterates Overweight rating on Praxis Precision Medicines stock - Investing.com Nigeria
Chardan Capital Brokers Lower Earnings Estimates for PRAX - Defense World
ATTENTION PRAX Shareholders: Lost Money on Praxis Precision Medicines, Inc.? Contact Levi & Korsinsky About Investigation - ACCESS Newswire
Praxis Precision Medicines (PRAX) to Release Quarterly Earnings on Tuesday - Defense World
Praxis Precision Medicines Q2 results disappoint, stock falls 5.55% - AInvest
What is HC Wainwright’s Forecast for PRAX Q3 Earnings? - Defense World
HC Wainwright Reaffirms Buy Rating for Praxis Precision Medicines (NASDAQ:PRAX) - Defense World
Praxis Precision Medicines’ Positive Earnings Call Highlights Vormatrigine Success - MSN
Praxis Precision Medicines: Marcio Firm's Insights - AInvest
What is Wedbush’s Forecast for PRAX Q3 Earnings? - Defense World
FY2029 Earnings Forecast for PRAX Issued By HC Wainwright - Defense World
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Praxis Precision Medicines Grants 3,875 Restricted Stock Units to Strategic New Hires - Stock Titan
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Q2 2025 Earnings Call Transcript - Insider Monkey
Will Praxis Precision Medicines Inc. stock split in the near futureDaily Pattern Analysis with Return Forecast - Newser
Praxis Precision Medicines Advances Epilepsy Treatment with Promising Study Results and Strong Financial Positioning - AInvest
Praxis Precision Medicines: A Dual-Platform Innovator Capturing the Future of Precision Neurology - AInvest
0.41%
0.88%
大文字化:
|
ボリューム (24 時間):